ÂÜÀòÂÒÂ×

Christopher Benoit has a diverse work experience in the biotechnology industry. Christopher is currently the Chief Executive Officer at Alphazyme LLC since April 2018. Christopher also owns their own company, Benoit Capital Partners LLC, since August 2016.

In the past, they served as the Chief Executive Officer and a Board Member at TwinStrand Biosciences from March 2018 to September 2018. At TwinStrand, they were responsible for leading the company out of the R&D lab and into the marketplace, focusing on rare variant detection in genetics.

From December 2014 to July 2016, Benoit worked at Enzymatics, A QIAGEN Company, where they held the positions of VP, Head of Reagents and Senior Vice President, Reagents. Christopher was responsible for strategic leadership and management of commercial, R&D, and support teams in the development and manufacturing of molecular biology solutions. Christopher also served as the primary face of Enzymatics to customers and cultivated key relationships.

Prior to that, they were the Chief Commercial Officer at Enzymatics from August 2012 to December 2013, where they focused on achieving revenue and profitability targets and developing international markets. Christopher also served as the President, Chief Operating Officer, and Co-Founder of Enzymatics from October 2006 to August 2012.

At New England Biolabs, Benoit worked as a Product Manager/DNA Polymerases from June 1995 to October 2006. Christopher played a significant role in product development, manufacturing scale-up, and quality control of DNA polymerases and other molecular biology tools. Christopher was also involved in customer interaction and the design of custom purification and QC strategies.

Overall, Benoit's work experience showcases their leadership, expertise in the biotechnology industry, and their ability to drive results and build relationships.

Christopher Benoit attended the University of Massachusetts Amherst from 1991 to 1995. During this period, they pursued a Bachelor of Science degree in Biochemistry.